RxNorm 1653196 NDC Crossover

insulin aspart 100 UNT/ML in 3 ML Cartridge

Related NDC Codes to RxNorm Concept 1653196

The following NDC codes crossover to the RxNorm Concept 1653196. This list is useful when crossing over from a given RxNorm code and the user is trying to choose a drug or product included in the NDC directory.

NDC	Proprietary Name	Non-Proprietary Name	Dosage Form	Route Name	Labeler Name	Status
0169-2001	Insulin Diluting Medium For Novolog	Water Injection	Injection, Solution	Intravenous; Subcutaneous	Novo Nordisk	ACTIVE
0169-2100	Novolog	Insulin Aspart	Injection, Solution	Intravenous; Subcutaneous	Novo Nordisk	ACTIVE
0169-2101	Novolog	Insulin Aspart	Injection, Solution	Intravenous; Subcutaneous	Novo Nordisk	ACTIVE
0169-3201	Fiasp	Insulin Aspart Injection	Injection, Solution	Subcutaneous	Novo Nordisk	ACTIVE
0169-3204	Fiasp	Insulin Aspart Injection	Injection, Solution	Subcutaneous	Novo Nordisk	ACTIVE
0169-3205	Fiasp	Insulin Aspart Injection	Injection, Solution	Subcutaneous	Novo Nordisk	ACTIVE
0169-3206	Fiasp	Insulin Aspart	Injection, Solution	Subcutaneous	Novo Nordisk	ACTIVE
0169-3303	Novolog	Insulin Aspart	Injection, Solution	Intravenous; Subcutaneous	Novo Nordisk	ACTIVE
0169-6338	Novolog	Insulin Aspart	Injection, Solution	Intravenous; Subcutaneous	Novo Nordisk	ACTIVE
0169-6339	Novolog	Insulin Aspart	Injection, Solution	Intravenous; Subcutaneous	Novo Nordisk	ACTIVE
0169-7501	Novolog	Insulin Aspart	Injection, Solution	Intravenous; Subcutaneous	Novo Nordisk	ACTIVE
50090-1664	Novolog	Insulin Aspart	Injection, Solution	Intravenous; Subcutaneous	A-s Medication Solutions	ACTIVE
50090-1678	Novolog	Insulin Aspart	Injection, Solution	Intravenous; Subcutaneous	A-s Medication Solutions	ACTIVE
73070-100	Insulin Aspart	Insulin Aspart	Injection, Solution	Intravenous; Subcutaneous	Novo Nordisk Pharma, Inc.	ACTIVE
73070-102	Insulin Aspart	Insulin Aspart	Injection, Solution	Intravenous; Subcutaneous	Novo Nordisk Pharma, Inc.	ACTIVE
73070-103	Insulin Aspart	Insulin Aspart	Injection, Solution	Intravenous; Subcutaneous	Novo Nordisk Pharma, Inc.	ACTIVE